Latest filingSep 02, 2026Most recent Form 4
ROIV
Roivant Sciences Ltd.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$4.36B9 sells
Net open-market-$4.36B3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period26transactions
- M · Option exercise · dominant15 · 58%
- S · Open-market sells9 · 35%
- F · Tax withholding2 · 8%
Activity by reported role
A joint filing can contribute to multiple roles51transactions
- PRES · dominant25 · 49%
- CIO20 · 39%
- IC5 · 10%
- Chief financial officer1 · 2%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (3)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSukhatme MayukhCommon Shares · Direct
18,630,739Aug 21, 2026
Venker EricCommon Shares · Direct
1,599,154Aug 28, 2026
Sukhatme MayukhStock Option (Right to Buy) · Direct
13,224,363Aug 21, 2026
Pulik RichardCommon Shares · Direct
271,810Aug 20, 2026
Venker EricStock Option (Right to Buy) · Direct
3,844,834Aug 28, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- SM-$36.5M
- VE-$7.2M
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
ROIV transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ROIV | Venker Eric | PRESIC | sale10b5-1 | 33.8k | -$123M | S | 0.0% | 09/02 | 08/28 | |
| ROIV | Venker Eric | PRESIC | sale10b5-1 | 166k | -$592M | S | 0.0% | 09/02 | 08/28 | |
| ROIV | Sukhatme Mayukh | PRESCIO | sale | 144k | -$528M | S | −4.4% | 08/22 | 08/21 | |
| ROIV | Sukhatme Mayukh | PRESCIO | sale | 17.5k | -$65.3M | S | −4.4% | 08/22 | 08/20 | |
| ROIV | Sukhatme Mayukh | PRESCIO | sale | 172k | -$642M | S | −4.4% | 08/22 | 08/19 | |
| ROIV | Sukhatme Mayukh | PRESCIO | sale | 31.8k | -$118M | S | −7.7% | 08/19 | 08/18 | |
| ROIV | Sukhatme Mayukh | PRESCIO | sale | 105k | -$384M | S | −7.7% | 08/19 | 08/18 | |
| ROIV | Sukhatme Mayukh | PRESCIO | sale | 284k | -$1.03B | S | −7.7% | 08/19 | 08/17 | |
| ROIV | Sukhatme Mayukh | PRESCIO | sale | 243k | -$881M | S | −7.7% | 08/19 | 08/14 |
Roivant Sciences Ltd. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Roivant Sciences Ltd.?
Venker Eric, Pulik Richard, Sukhatme Mayukh.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Venker Eric reported a sale on Aug 28, 2026 valued at $123M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $43,674,607.82. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.